1. Home
  2. BLTE vs RNW Comparison

BLTE vs RNW Comparison

Compare BLTE & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • RNW
  • Stock Information
  • Founded
  • BLTE 2018
  • RNW 2011
  • Country
  • BLTE United States
  • RNW United Kingdom
  • Employees
  • BLTE N/A
  • RNW N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • RNW Electric Utilities: Central
  • Sector
  • BLTE Health Care
  • RNW Utilities
  • Exchange
  • BLTE Nasdaq
  • RNW Nasdaq
  • Market Cap
  • BLTE 2.1B
  • RNW 2.2B
  • IPO Year
  • BLTE 2022
  • RNW N/A
  • Fundamental
  • Price
  • BLTE $56.40
  • RNW $6.21
  • Analyst Decision
  • BLTE Strong Buy
  • RNW Strong Buy
  • Analyst Count
  • BLTE 4
  • RNW 1
  • Target Price
  • BLTE $96.67
  • RNW $7.50
  • AVG Volume (30 Days)
  • BLTE 37.7K
  • RNW 915.5K
  • Earning Date
  • BLTE 05-12-2025
  • RNW 06-04-2025
  • Dividend Yield
  • BLTE N/A
  • RNW N/A
  • EPS Growth
  • BLTE N/A
  • RNW N/A
  • EPS
  • BLTE N/A
  • RNW 0.04
  • Revenue
  • BLTE N/A
  • RNW $1,006,524,942.00
  • Revenue This Year
  • BLTE N/A
  • RNW N/A
  • Revenue Next Year
  • BLTE N/A
  • RNW $38.75
  • P/E Ratio
  • BLTE N/A
  • RNW $158.29
  • Revenue Growth
  • BLTE N/A
  • RNW N/A
  • 52 Week Low
  • BLTE $32.25
  • RNW $5.15
  • 52 Week High
  • BLTE $86.53
  • RNW $7.49
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 39.21
  • RNW 55.37
  • Support Level
  • BLTE $49.00
  • RNW $6.03
  • Resistance Level
  • BLTE $60.21
  • RNW $6.23
  • Average True Range (ATR)
  • BLTE 3.55
  • RNW 0.25
  • MACD
  • BLTE -0.57
  • RNW 0.05
  • Stochastic Oscillator
  • BLTE 41.67
  • RNW 96.95

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks: